High Oil Prices Will Hurt Colgate-Palmolive Stock According to Wall Street

Core Viewpoint - Colgate-Palmolive has been downgraded from Buy to Hold by TD Cowen due to surging oil-based input costs and weak North American sales, leading to earnings estimate cuts for 2026-2027 despite solid Q4 2025 results [2][5][7]. Group 1: Financial Performance - Colgate-Palmolive reported Q4 2025 non-GAAP EPS of $0.95, exceeding the consensus estimate of $0.91, with revenue of $5.23 billion, surpassing the $5.13 billion estimate and growing 5.8% year-over-year [9]. - The company's full-year free cash flow reached $3.634 billion, and it returned $2.9 billion to shareholders through dividends and buybacks [9]. Group 2: Market Conditions - Oil-based input costs have surged 33.9% monthly due to the Iran War, with tallow prices increasing 40% year-over-year, impacting Colgate's margins [2][7]. - North America experienced a 1.8% decline in organic sales in Q4 2025, contributing to concerns about the need for incremental investment to improve sales [3][8]. Group 3: Analyst Insights - TD Cowen cut its price target for Colgate-Palmolive from $96 to $85, reflecting the inflationary pressures from rising oil prices and weak domestic sales [5][6]. - The stock has fallen 13.53% over the past month, aligning closely with TD Cowen's new price target, while the analyst consensus target remains higher at $97.68 [11]. Group 4: Competitive Position - Colgate holds a 41.2% global market share in toothpaste, which is a significant competitive advantage, particularly in emerging markets [3][13]. - Despite the strong market position, domestic headwinds and oil-driven cost inflation are expected to suppress near-term earnings growth [13].